Add to ORKGThere has been significant progress in using induced plu-ripotent stem cells (iPSCs) for modeling of human disease by harvesting somatic cells from patients, reprogramming the somatic cells into a pluripotent state, and then differen
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement therapy approa...
The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution to the f...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defi...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
Induced pluripotent stem cells (iPSC) technology has propelled the field of stem cells biology, pro...
Induced pluripotent stem cells (iPSC) are one of the key discoveries in cell biology of the last dec...
Induced pluripotent stem cells (iPSC) are one of the key discoveries in cell biology of the last dec...
Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells thro...
The recent generation of induced pluripotent stem (iPS) cells from adult human somatic cells has int...
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement therapy approa...
The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution to the f...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defi...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
In the field of regenerative medicine, the development of induced pluripotent stem (iPS) cells may r...
Induced pluripotent stem cells (iPSC) technology has propelled the field of stem cells biology, pro...
Induced pluripotent stem cells (iPSC) are one of the key discoveries in cell biology of the last dec...
Induced pluripotent stem cells (iPSC) are one of the key discoveries in cell biology of the last dec...
Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells thro...
The recent generation of induced pluripotent stem (iPS) cells from adult human somatic cells has int...
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
The development of human embryonic stem cell technology1 and the ability to differentiate these plur...
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement therapy approa...